insights_auto
Why is URGN up 5.01%?
Dive Deeperchevron_right
URGN:NASDAQ
Urogen Pharma Ltd
$34.36
arrow_upward
+5.01%(+1.64) 1D
$34.36
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for URGN...
Open
$32.95
High
$34.88
Low
$32.45
Mkt. cap
1.68B
Avg. vol.
1.01M
Volume
0.00
52-wk high
$50.81
52-wk low
$16.50
EPS
-$1.98
Beta
1.57
Shares outstanding
48.88M
No. of employees
300
Open
$32.95
High
$34.88
Low
$32.45
Mkt. cap
1.68B
Avg. vol.
1.01M
Volume
0.00
52-wk high
$50.81
52-wk low
$16.50
EPS
-$1.98
Beta
1.57
Shares outstanding
48.88M
No. of employees
300
News stories
From web sources and news partners
Investing.com
·
17 hours ago
UroGen doses first patient in UGN-501 bladder cancer trial
About Urogen Pharma Ltd
CEO-
Employees300
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteurogen.com